arrow
L

Lynn M. Matrisian

boston consulting group (bcg)
H指数:99
被引数:4.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RISK OF PANCREATIC CANCER IN GLYCEMICALLY DEFINED NEW-ONSET DIABETES: A PROSPECTIVE COHORT STUDY

新发糖尿病中基于血糖定义的胰腺癌风险:一项前瞻性队列研究

2025-07-070
OAAI
Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database

肺内转移型和肝内转移型胰腺癌的临床结局与分子特征:真实世界证据数据库的结果

2025-03-130
OA
Keratin 17 modulates the immune topography of pancreatic cancer

角蛋白17调节胰腺癌的免疫形貌

2024-05-102
OAAI
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
2024-02-0324
OAAI
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
2024-01-160
PRE
Keratin 17 excludes CD8-positive T cells and recruits CD163-positive macrophages in pancreatic ductal adenocarcinoma
2024-01-160
PRE
Impact of KRAS mutations and co-mutations on clinical outcomes in Pancreatic Ductal Adenocarcinoma
2023-12-010
PRE
Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature
2021-01-0623
OA
Evaluation of next generation sequencing of DNA and RNA from archival formalin-fixed, paraffin-embedded pancreatic cancer tissue: A pilot study of the SEER-linked virtual tissue repository
2020-08-150
PRE